![Vikram Karnani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vikram Karnani
Nessuna posizione attualmente
Profilo
Vikram Karnani served as the VP-Therapeutics & Cell Therapy Business at Fresenius Kabi USA LLC from 2011 to 2014.
He then worked as the Chief Commercial Officer & Executive VP at Horizon Therapeutics Plc from 2018 to 2020.
Prior to his professional roles, he obtained a graduate degree from Case Western Reserve University, an undergraduate degree from the University of Mumbai, and an MBA from Kellogg School of Management.
Precedenti posizioni note di Vikram Karnani
Società | Posizione | Fine |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Direttore Tecnico/Scientifico/R&S | 01/11/2023 |
Fresenius Kabi USA LLC
![]() Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi USA LLC provides healthcare products and services. It specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The firm''s products are used to help care for critically and chronically ill patients. The company was founded by Eduard Fresenius in 1912 and is headquartered in Lake Zurich, IL. | Corporate Officer/Principal | 01/08/2014 |
Formazione di Vikram Karnani
Kellogg School of Management | Masters Business Admin |
Case Western Reserve University | Graduate Degree |
University of Mumbai | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Horizon Therapeutics Plc
![]() Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Fresenius Kabi USA LLC
![]() Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi USA LLC provides healthcare products and services. It specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The firm''s products are used to help care for critically and chronically ill patients. The company was founded by Eduard Fresenius in 1912 and is headquartered in Lake Zurich, IL. | Health Technology |
- Borsa valori
- Insiders
- Vikram Karnani